Hedera Dx News

Symposium: Liquid Biopsy in Molecular Pathology - From Complementary Testing to Clinical Integration

Introducing a Hedera Dx board member: Tobias Silberzahn

Lunch Symposium: From Innovation to Clinical Practice - Quality, Robustness, and Readiness of Liquid Biopsy

Webinar: Decentralizing Liquid Biopsy in Oncology - From Innovation to Routine Clinical Practice

Hedera Dx participates in the Swiss artificial intelligence initiative NAIPO

Hedera Dx Secures €15 Million Series A to bring modern cancer care to patients across the globe